Skip to main content
. Author manuscript; available in PMC: 2018 Jul 11.
Published in final edited form as: Pharmacogenomics. 2014 Apr;15(6):759–774. doi: 10.2217/pgs.14.39

Table 4.

Late stage gene-expression (stage III, 24–48 h) responses.

GO ID Biological process Bonferroni p-value
6629 Lipid metabolic process 2.30 × 10−15
9719 Response to endogenous stimulus 9.40 × 10−15
6955 Immune response 5.02 × 10−14
70887 Cellular response to chemical stimulus 1.90 × 10−9
33993 Response to lipid 2.14 × 10−8
40011 Locomotion 7.25 × 10−8
32879 Regulation of localization 1.51 × 10−7
72358 Cardiovascular system development 1.61 × 10−6
48514 Blood vessel morphogenesis 3.60 × 10−6
12501 Programmed cell death 0.000580134

Biological processes significantly modified following rosiglitazone treatment are presented. Bonferroni-adjusted p-values are provided for nonredundant gene ontology terms.